HUMA
Humacyte, Inc. · Healthcare
Director and 10% owner Brady W Dougan sold $2.7M of Humacyte, Inc.
Sold$2,729,332
$9.10Price
300,000Shares
−1%Stake
What HUMA did after the filing
- The stock from Thu, Dec 16 close, $8.71
- −38.2%
- S&P 500, same days
- −3.2%
Measured over 30 trading days, to the Jan 31 close.
Traded Tue, Dec 14. Filed Thu, Dec 16, 2:47 PM ET, during the session. Returns use the Dec 16 close and the Jan 31 close. Not investment advice.